| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.092 | 0.04 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.083 | 0.05 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |